Articles

Poll

Podcasts

Slideshows

Videos

Rheumatology

Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

The rheumatology month in review emphasizes new approvals and best-in-class efficacy data.

7 Rheumatology Headlines You Missed in August 2025

Rosnilimab shows promising long-term efficacy in treating moderate-to-severe rheumatoid arthritis.

Rosnilimab Continues Best-in-Disease Profile Responses for Rheumatoid Arthritis

SetPoint Medical's FDA-approved device offers a new neuroimmune therapy for rheumatoid arthritis, enhancing treatment options without immune risks.

FDA Approves Neuroimmune Modulation Therapy for Rheumatoid Arthritis

A study of approximately 1.2 million children found no evidence that early exposure to aluminum from vaccines increases the risk of autoimmune, allergic, or neurodevelopmental conditions.

No Link Found Between Aluminum in Childhood Vaccines and Autoimmune Disorders

Populations most affected by RA are also growing younger and broader since 1990.

Rheumatoid Arthritis Burden Has Surged Over Last 30 Years

Depressive symptoms in the first 2 years after diagnosis were linked to lower odds of achieving remission in both RA and PsA.

Depression Reduces Remission Likelihood in Rheumatoid, Psoriatic Arthritis

Investigators call for faster diagnosis and better treatment for psoriatic arthritis to avoid unnecessary complication and suffering.

Study Finds Diagnostic Delay, Less Intensive Therapy Use in PsA than RA

The Phase 2b RENOIR trial met its primary endpoint and key secondary endpoints in patients with RA in new 12-week data.

Rosnilimab Demonstrates Historic Responses for Rheumatoid Arthritis

Tocilizumab-anoh will be available in both intravenous and subcutaneous formulations. 

Tocilizumab Biosimilar Approved for Rheumatological Diseases, COVID-19 

Tocilizumab and other biological drugs were particularly efficacious in lowering overall hemostatic potential, mitigating blood clot risks.

Early Control of Rheumatoid Arthritis Improves Hemostatic Imbalance

The HCPLive rheumatoid arthritis page is a comprehensive resource for clinical news and insights on arthritis. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for RA, and more.